Issuer Information

EDGAR: Contact Information
  • Name:
    Maxona Pharmaceuticals, Inc.
  • Address:
    101 Lindenwood Drive
    Suite 225
    Malvern, PENNSYLVANIA 19355
  • Phone:
    484.681.5626
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Corporation
  • Incorporated:
    Over 5 years ago
  • Previous Names:
    None

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
558809: 0001857448-25-000002
First Sale: 2025-06-04
Security Type(s): Equity
Offer Amount: $5,000,000
Amount Sold: $900,163
Remaining: $4,099,837
06b

AZ, CA, CO, CT, NV, NY, PA, TN, TX, WI,

373888: 0001857448-21-000001
First Sale: 2021-04-09
Security Type(s): Equity
Offer Amount: $10,000,000
Amount Sold: $5,555,000
Remaining: $4,445,000
06b No Notices in EFD for this offering.

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.